Clinical Trial Update: Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA

View source ↗

Summary

A completed ancillary study to the CARDIA clinical trial that investigates inflammation genomics in relation to atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Thrombosis

Snippet

Sponsor: University of Washington | Conditions: Cardiovascular Diseases, Atherosclerosis | Status: COMPLETED